The global enteric disease testing market is progressing steadily at a CAGR of 2.40% from 2013 to 2019. The market was valued at US$3.1 bn in 2012. By the end of 2019, the global enteric disease testing market is expected to be valued at US$3.6 bn, according to a research report released by Transparency Market Research. The report, titled "Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", is available for sale on the company website.
Get Report Sample and Customization:
According to the report, the global enteric disease testing market is driven by the growing prevalence of enteric diseases, combined with the mounting pressure to create early diagnostic tools for the diseases. The highest occurrence is observed in developing nations, where sub-standard drainage systems and lack of disinfection tools have created a high prevalence of diseases afflicting the lower and middle class citizens. The high density of population in many developing countries also plays a major role in driving the global enteric disease testing market.
The report notes that the healthcare industry is pushing for early diagnosis of enteric diseases in order to facilitate speedy recovery of patients. To aid this, government awareness programs are held, along with rising focus on research and development on enteric diseases and their cure.Some of the common symptoms of enteric diseases are anorexia, vomiting, weight loss, nausea, diarrhea, high and consistent fever, and stomach pains or cramps. It is suggested that a patient apply for diagnosis of enteric diseases should they encounter these symptoms.
The report explores the global enteric disease testing market through all 12 major types of enteric diseases, which includes clostridium difficile mediated infection, salmonellosis, giardiasis, cryptosporidiosis, campylobacteriosis, and amebiasis.The report thoroughly explains one of the major trends in the global enteric disease testing market, of shifting away from culture methods. Culture tests have limited diagnostic strength and bring with them a host of other issues, including the lack of availability of skilled workers, lack of medical infrastructure, and high costs.
The geographically competitive landscape of the global enteric disease testing market reveals North America to be the largest region, owing to the presence of most of the top players in the global enteric disease testing market. However, the report states that Asia Pacific is expected to be the fastest growing region in the global enteric disease testing market, due to the region's high population density and lack of water recycling systems. Most regions in Asia Pacific have under-par sanitation, unsafe drinking water, and unhygienic living conditions.The key players in the global enteric disease testing market, as discussed in the report, are bioMerieux, Becton Dickinson, Cepheid, Bio-Rad, Meridian Bioscience, Trinity Biotech, Alere, DiaSorin, and Biomerica.
Full Research Report on Global Enteric Disease Testing Market with detailed figures and segmentation at: http://www.transparencymarketresearch.com/enteric-disease-testing-market.html